Search

Displaying results 9041 - 9050 of 10000 in total
  1. Drug

    Cinsebrutinib

    go.drugbank.com/drugs/DB21640
    Experimental

    Cinsebrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  2. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  3. Drug

    Glumetinib

    go.drugbank.com/drugs/DB15630
    Investigational

    Glumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).

  4. Drug

    Benapenem

    go.drugbank.com/drugs/DB18883
    Investigational

    Benapenem is under investigation in clinical trial NCT04505683 (A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (Cuti) or Acute Pyelonephritis

  5. Drug

    Cedirogant

    go.drugbank.com/drugs/DB18951
    Investigational

    Cedirogant is under investigation in clinical trial NCT05044234 (A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

  6. Drug

    Forimtamig

    go.drugbank.com/drugs/DB19015
    Investigational

    Forimtamig is under investigation in clinical trial NCT06055075 (A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-based Treatment Combinations in Participants With Relapsed

  7. Drug

    Mazdutide

    go.drugbank.com/drugs/DB19099
    Investigational

    Mazdutide is under investigation in clinical trial NCT06143956 (A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-specific-appendices (Isas) in Adult Participants With

  8. Drug

    Recombinant human kallikrein-1

    go.drugbank.com/drugs/DB19232
    Investigational

    Recombinant human kallikrein-1 is under investigation in clinical trial NCT01845064 (A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients).

  9. Drug

    rDEN3Delta30

    go.drugbank.com/drugs/DB33999
    Experimental

    rDEN3Delta30 is a biologic drug. rDEN3Delta30 is under investigation in clinical trial NCT07831473 (Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults).

  10. Drug

    Isospaglumic acid

    go.drugbank.com/drugs/DB19650
    Investigational

    Isospaglumic acid is under investigation in clinical trial NCT06800274 (Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction). … Isospaglumic acid is a small molecule drug.

    Synonyms: N-acetylaspartylglutamic acid